CGC
Canopy Growth Corp
NASDAQ: CGC · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$1.11
+1.83% today
Updated 2026-04-30
Market cap
$619.73M
P/E ratio
—
P/S ratio
2.23x
EPS (TTM)
$-1.36
Dividend yield
—
52W range
$1 – $2
Volume
11.0M
Canopy Growth Corp (CGC) Financial statements
SEC filings — annual and quarterly data.
Profit margin
-117.30%
Operating margin
-17.60%
ROE
-48.50%
ROA
-2.64%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2010 | $549.00 | $-26918.00 | 100.00% | -4,903.10% | -4,903.10% |
| 2011 | $4488.00 | $-24068.00 | 100.00% | -436.27% | -536.27% |
| 2012 | — | $-21393.00 | — | — | — |
| 2013 | $4144.00 | $-64608.00 | 100.00% | -1,559.07% | -1,559.07% |
| 2014 | — | $-932925.00 | — | — | — |
| 2014 | $1.15M | $-8.93M | 36.17% | -588.05% | -779.58% |
| 2015 | $1.15M | $-8.93M | 36.17% | -675.34% | -779.58% |
| 2016 | $12.70M | $-3.50M | 149.51% | -21.65% | -27.53% |
| 2017 | $39.90M | $-16.61M | 94.33% | -38.14% | -41.63% |
| 2018 | $77.95M | $-54.13M | 95.18% | -101.19% | -69.45% |
| 2019 | $226.34M | $-670.09M | 39.29% | -244.61% | -296.06% |
| 2020 | $398.77M | $-1.32B | -7.95% | -418.53% | -331.35% |
| 2021 | $546.65M | $-1.74B | 12.25% | -227.47% | -319.20% |
| 2022 | $475.70M | $-310.04M | -39.40% | -214.17% | -65.18% |
| 2023 | $333.25M | $-3.28B | -19.06% | -789.34% | -983.68% |
| 2024 | $297.15M | $-657.27M | 27.22% | -76.97% | -221.19% |
| 2025 | $269.00M | $-598.12M | 29.56% | -43.55% | -222.35% |